Metallodrugs in cancer nanomedicine

Cites (441)

Items 401–441 of 441

1. Perfluorocarbon nanodroplets stabilized with cisplatin-prodrug-constructed lipids enable efficient tumor oxygenation and chemo-radiotherapy of cancer
   Yao Li, Liangzhu Feng, Danlei Tao, Huiquan Tao, Xiaoyan Zhong, Chao Liang, Yujie Zhu, Bing Hu, Zhuang Liu, Yuanyi Zheng · 2020 · Nanoscale
2. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer
   Yupeng Wang, Zhijian Luo, Dongfang Zhou · 2021 · Biomaterials Science
3. The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer
   Conglian Yang, Kun Tu, Hanlu Gao, Liao Zhang, Yu Sun, Ting Yang, Li Kong, Defang Ouyang, Zhiping Zhang · 2019 · Biomaterials
4. Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer
   Muhammad Nafees, Cai‐Ping Tan, Uroosa Nawaz · 2020 · Inorganic Chemistry
5. Engineered Nanoscale Vanadium Metallodrugs for Robust Tumor‐Specific Imaging and Therapy
   Shihua Li, Yongling Chen, Wei Zhu, Wen Yang, Zhaowei Chen, Jibin Song, Xiaorong Song, Xian Chen, Huanghao Yang · 2021 · Advanced Functional Materials
6. Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells
   Natalia Sanz del Olmo, Marcin Hołota, Sylwia Michlewska · 2020 · Pharmaceutics
7. DNA Photocleavage by Non-innocent Ligand-Based Ru(II) Complexes
   Yangyang Zhang, Qianxiong Zhou, Yue Zheng, Ke Li, Guoyu Jiang, Yuanjun Hou, Baowen Zhang, Xuesong Wang · 2016 · Inorganic Chemistry
8. Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model
   Taro Shimizu, Amr Selim Abu Lila, Miho Nishio, Yusuke Doi, Hidenori Ando, Masami Ukawa, Yu Ishima, Tatsuhiro Ishida · 2017 · Cancer Science
9. Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
   Jerneja Kladnik, James P. C. Coverdale, Jakob Kljun · 2021 · Cancers
10. Antigen presentation by cisplatin‐activated macrophages: Role of soluble factor(s) and second messengers
    Rana AK Singh, Ajit Sodhi · 1998 · Immunology and Cell Biology
11. The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias
    Charles L. Spurr, Taylor R. Smith, MATTHEW H. BLOCK · 1950 · The American Journal of Medicine
12. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)
    Stefano Chong Hun Kim, Marine Jary, Thierry André et al. · 2017 · BMC Cancer
13. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Line V. Hjelle, Per Ole M. Gundersen, Ragnhild Hellesnes, Mette Sprauten, Marianne Brydøy, Torgrim Tandstad, Tom Wilsgaard, Sophie D. Fosså, Jan Oldenburg, Roy Martin Bremnes et al. · 2018 · Acta Oncologica
14. Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles
    Hongzhi Qiao, Lei Zhang, Dong Fang · 2021 · Chemical Science
15. Challenges and Chances in the Preclinical to Clinical Translation of Anticancer Metallodrugs
    Isabella Poetsch, Dina Baier, Bernhard K. Keppler, Walter Berger · 2019 · Royal Society of Chemistry eBooks
16. Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol
    Alexia Kagiava, George Theophilidis, Irene Sargiannidou, Kyriacos C. Kyriacou, Kleopas A. Kleopa · 2015 · Neuropharmacology
17. Studying the reactivity of “old” Cu(II) complexes for “novel” anticancer purposes
    Quim Peña, Júlia Lorenzo, Giuseppe Sciortino, Sergi Rodríguez-Calado, Jean‐Didier Maréchal, Pau Bayón, Ariane Jalila Simaan, Olga Iranzo, Mercè Capdevila, Òscar Palacios · 2019 · Journal of Inorganic Biochemistry
18. An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt II Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
    Eugen Merkul, Joey A. Muns, Niels J. Sijbrandi, Hendrik‐Jan Houthoff, Bart A. Nijmeijer, Gerro van Rheenen, Jan Reedijk, Guus A.M.S. van Dongen · 2020 · Angewandte Chemie International Edition
19. On the hydrolytic stability of unsymmetric platinum( iv ) anticancer prodrugs containing axial halogens
    Zoufeng Xu, Wai Kit Tang, Qiyuan Zhou · 2021 · Inorganic Chemistry Frontiers
20. Photoswitching the Cytotoxic Properties of Platinum(II) Compounds
    Andreu Presa, Rosa F. Brissos, Ana Belén Caballero · 2015 · Angewandte Chemie
21. Rationale and clinical implication of combined chemotherapy with cisplatin and oestrogen in prostate cancer: primary evidence based on methylation analysis of oestrogen receptor‐α
    Nobuko Moriyama‐Gonda, Hiroaki Shiina, Masaharu Terashima · 2007 · British Journal of Urology
22. Docetaxel versus docetaxel plus cisplatin for non-small-cell lung cancer: a meta-analysis of randomized clinical trials
    Ang Li, Zhijian Wei, Han Ding · 2017 · Oncotarget
23. Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what’s known and what’s next
    Tao Jiang, Caicun Zhou, Jie Hu · 2019 · Translational Lung Cancer Research
24. Ultra-Small Platinum Nanoparticle-Enabled Catalysis and Corrosion Susceptibility Reverse Tumor Hypoxia for Cancer Chemoimmunotherapy
    Fang‐Hsuean Liao, Chun‐Nien Yao, Te‐Haw Wu, Shuping Chen, Lu‐Chen Yeh, Shu‐Yi Lin, Wen‐Jye Lin · 2021 · ACS Applied Bio Materials
25. A class of Pt( iv ) triple-prodrugs targeting nucleic acids, thymidylate synthases and histone deacetylases
    Xiao-Jing Ding, Ran Zhang, Rui-Ping Liu · 2020 · Inorganic Chemistry Frontiers
26. A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall
    Sylvie Bonvalot, Piotr Lukasz Rutkowski, Juliette Thariat et al. · 2018 · Annals of Oncology
27. Pincer‐Based Heterobimetallic Pt(II)/Ru(II), Pt(II)/Ir(III), and Pt(II)/Cu(I) Complexes: Synthesis and Evaluation of Antiproliferative Properties
    Benoı̂t Bertrand, Geoffrey Gontard, Candice Botuha · 2020 · European Journal of Inorganic Chemistry
28. Carboplatin—gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration
    Constantin A Dasanu, Thomas J. Herzog, Doru T Alexandrescu · 2009 · Journal of Oncology Pharmacy Practice
29. Détection de métastases hépatiques du cancer colorectal sous chimiothérapie
    Christophe Beziat, F. Pilleul, Delphine Yzebe · 2004 · Journal de Radiologie
30. Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk
    Erika Joelle Lampert, John L. Hays, Elise C. Kohn, Christina M. Annunziata, Lori M. Minasian, Minshu Yu, Nicolas Gordon, Tristan M. Sissung, Victoria L. Chiou, William Douglas Figg et al. · 2019 · Oncotarget
31. Photochemistry and in vitro anticancer activity of Pt( iv )Re( i ) conjugates
    Zhouyang Huang, A. Paden King, James H. Lovett · 2021 · Chemical Communications
32. Squaramide-Based Pt(II) Complexes as Potential Oxygen-Regulated Light-Triggered Photocages
    Kevin Morales, Katia G. Samper, Quim Peña · 2018 · Inorganic Chemistry
33. Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound
    Ming Sen Jiang, Shanhe Li, Junmiao Wu · 2020 · Journal of Inorganic Biochemistry
34. Basic Coordination Chemistry of Ruthenium
    Mark A.W. Lawrence, Jimmie L. Bullock, Alvin A. Holder · 2017
35. Carbohydrate Metabolism of Tumours
    Isaac Berenblum, Ernst Boris Chain, Norman George Heatley · 1940 · Nature
36. First‐line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study
    SK Tay, A Ilanchadran, TY Tan · 2006 · BJOG An International Journal of Obstetrics & Gynaecology
37. Towards Imaging Pt Chemoresistance Using Gd(III)‐Pt(II) Theranostic MR Contrast Agents
    Casey J. Adams, Thomas J. Meade · 2021 · ChemMedChem
38. A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer.
    Biyun Wang, Xichun Hu, Si Sun et al. · 2012 · Journal of Clinical Oncology
39. Ruthenium: Inorganic & Coordination ChemistryBased in part on the article Ruthenium: Inorganic & Coordination Chemistry by Bruno Chaudret & Sylviane Sabo‐Etienne which appeared in theEncyclopedia of Inorganic Chemistry, First Edition.
    Sylviane Sabo‐Etienne, Mary Grellier · 2005 · Encyclopedia of Inorganic Chemistry
40. Titanium: Inorganic & Coordination ChemistryBased in part on the article Titanium: Inorganic & Coordination Chemistry by Charles A. McAuliffe & Neil Bricklebank which appeared in the Encyclopedia of Inorganic Chemistry, First Edition .
    Ann M. Valentine · 2005 · Encyclopedia of Inorganic and Bioinorganic Chemistry
41. Gold: Inorganic & Coordination Chemistry
    Jagadese J. Vittal, Richard J. Puddephatt · 2005 · Encyclopedia of Inorganic and Bioinorganic Chemistry